Password Reset
Forgot your password? Enter the email address you used to create your account to initiate a password reset.
Forgot your password? Enter the email address you used to create your account to initiate a password reset.
As we look back on 2024, the Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine (PACCSM) remains at the forefront of advancing care for acute and chronic lung conditions. Our team excels in clinical innovation, research breakthroughs, and educational leadership across diverse areas, including asthma, COPD, lung transplantation, advanced lung disease, and more.
This year, we’ve made significant strides in research and clinical program development, earning accolades for our work across the field of pulmonology and lung surgery at our UPMC hospitals.
We’re proud to highlight these achievements and invite you to explore more about our team and programs. We hope you’ll consider nominating UPMC in the U.S. News & World Report 2025 "Best Hospitals" survey as we continue our mission of delivering exceptional care.
Respectfully,
Alison Morris, MD
Professor of Medicine, Immunology, and Clinical and Translational Research
Division Chief, Pulmonary, Allergy and Critical Care Medicine
Director, Center for Medicine and the Microbiome
UPMC Chair in Translational Pulmonary and Critical Care Medicine
Affiliated with the University of Pittsburgh School of Medicine, UPMC Presbyterian Shadyside is proud to be nationally ranked by U.S. News & World Report for excellence in pulmonology and lung surgery.
Alison Morris, MD, MS, Division Chief and professor of Medicine, recently received renewal of their NIH R38 grant funding their research titled "Pittsburgh Innovation in Collaborative Training of Residents Alliance.”
John Evankovich, MD, Medical Director of the UPMC Jameson ICU and assistant professor of Medicine, was awarded NIH R03 grant funding for his project titled "Fibronectin Extra Domain A Degradation as an Antifibrotic Approach in Lung Fibrosis."
Priya Borker, MD, assistant professor of Medicine, received grant funding on her new K23 supporting her research titled "Understanding the association of sleep on monocyte action in HIV infection.”
John Evankovich, MD, received an NIH R56 grant for this research titled "Indole Metabolites as Xenobiotic Danger signals in Acute Lung Injury.” Dr. Evankovich studies the molecular biology of lung injury. His laboratory is interested in the intersection of three molecular systems in the innate immune system, and how they influence inflammation and cell death pathways in the lung.
Oliver Eickelberg, MD, FERS, ATSF, and Marta Bueno, PhD, received an NIH R01 grant for their research titled "Role of Plasma Cells in Chronic Rejection after Lung Transplantation." Dr. Eickelberg's research focuses on deciphering the mechanisms of tissue fibrosis, particularly in idiopathic pulmonary fibrosis and chronic lung allograft dysfunction after transplantation. Dr. Bueno’s research focus has revolved around diseases characterized by abnormal tissue repair and exaggerated remodeling, including pulmonary hypertension and scleroderma.
Chadi Hage, MD, received an NIH R01 for his research titled "An Automated Frailty Scoring System for Lung Transplantation Based on Bio-Geo-Composition." Dr. Hage’s research focuses on fungal diagnostics and lung transplant outcome studies.
Division Research Published in 2024
Discusses the role of the lung microbiome in acute cellular rejection and its impact on lung transplant outcomes. (American Journal of Respiratory and Critical Care Medicine)
Highlights the protective role of neutrophils and galectin-3 in combating bacterial infections and respiratory failure. (Nature Communications)
Explores the connection between inflammatory profiles and brain dysfunction in ventilated patients with acute respiratory failure. (Annals of the American Thoracic Society)
Examines how hyperinflammatory subphenotypes influence code status decisions in patients with severe respiratory conditions. (ScienceDirect)
Investigates the mechanisms of pulmonary edema in ARDS caused by COVID-19 and its physiological impacts. (American Journal of Physiology-Lung Cellular and Molecular Physiology)
Reports on the development of resistance to advanced antibiotics in multidrug-resistant bacterial infections. (JAC-Antimicrobial Resistance | Oxford Academic)
Analyzes the role of COVID-19 convalescent plasma and patient-specific immune responses in survival outcomes. (PubMed)
Discusses how antibiotic use during influenza can alter immune responses, increasing susceptibility to secondary infections. (PubMed)
Examines the effects of glucocorticoids on systemic immune responses in acute respiratory failure. (PubMed)
Explores the clinical and biological distinctions in ARDS patients with pre-existing COPD or emphysema. (PubMed)
Identifies distinct subphenotypes of long COVID symptoms and their associated health outcomes. (BMJ Open)
Investigates the dynamic interplay between the host and microbiota in the context of acute respiratory failure. (Nature Communications)
As the number of vaping users in the United States continues to rise, the UPMC Comprehensive Lung Center is combatting the vaping epidemic with the launch of a new Vaping Clinic. The clinic’s main goals are to alleviate patients’ symptoms and increase knowledge on vaping-induced lung injury.Specifically, the clinic is for patients who vape and are interested in assessment of their lung health or are experiencing respiratory symptoms, such as coughing, shortness of breath, coughing up sputum, recurrent infections, bronchitis, and asthma-like symptoms.
New robotic technology is now available at UPMC Hanover to diagnose lung cancer earlier. The first two procedures at UPMC Hanover were performed using the Ion® by Intuitive, a new robotic-assisted system. Ayman Bishay, MD, and Nicolas Habib, MD, both pulmonologists, performed these robotic biopsies, with assistance from Troy Moritz, DO, FACOS, chief of thoracic surgery in central Pa., on patients whose potentially cancerous nodules or lesions in their lungs were difficult to access with traditional biopsy tools.
UPMC is excited to announce our partnership with INTERLINK COE Networks & Programs as an addition to its solid organ transplant network. This partnership includes the adult transplant programs at UPMC Presbyterian, pediatric transplant programs at UPMC Children’s Hospital of Pittsburgh, and kidney transplantation at UPMC Harrisburg.The UPMC Lung Transplant Program received an additional designation as part of INTERLINK’s ELITE status, which is the highest ranking for their Programs of Excellence. To attain this level, programs must demonstrate superior results across a wide range of validated risk-adjusted metrics.
UPMC experts in north central Pa. now have a new tool to use in the battle against lung cancer – with the introduction of the Ion® by Intuitive robotic bronchoscopy system at UPMC Williamsport.
Under the leadership of Belinda Rivera-Lebron, MD, MS, director of the UPMC Acute Pulmonary Embolism Program and director of the UPMC Chronic Thromboembolic Pulmonary Hypertension Program, UPMC Presbyterian has achieved a prestigious accreditation as a Pulmonary Embolism Center of Excellence™ by the National PERT Consortium™. The PERT Consortium™ emphasizes that this designation “highlights UPMC’s commitment to delivering outstanding, evidence-based care for patients with pulmonary embolism and also marks a significant milestone in the shared mission to advance treatment and improve patient outcomes for pulmonary embolism.”
Oliver Eickelberg, MD, was appointed as Executive Vice Chair for Academic Affairs effective June 1, 2024. He joined the Division of Pulmonary, Allergy, Critical Care and Sleep Medicine (PACCSM) at the University of Pittsburgh in 2020, where he holds the Dorothy P. and Richard P. Simmons Chair for Pulmonary Research and has acted as Vice Chair of Basic and Translational Research for the last four years.
PACCSM fellows were honored with numerous awards including an Academic Sleep and Pulmonary Integrated Research/Clinical Fellowship (AIRE), awarded to Catherine Tarantine, MD; a BWF Physician Scientist Incubator Program Scholarship, awarded to Tina Okereke, MD; 1st place in the ATS Teaching Competition, awarded to Rachel Wojcik, MD; a travel award, awarded to Kassandra Allbright, MD; and abstract scholarships, awarded to Hiam Naiditch, MD (in Critical Care), Kassandra Allbright, MD (in Clinical Problems), Peter Nauka, MD (in Thoracic Oncology), and Muhtadi Alnababteh, MD (in Respiratory Cell and Molecular Biology).PACCSM faculty including Anuradha Ray, PhD, Melanie Königshoff, MD, PhD, Georgios Kitsios, MD, PhD, Corrine Kliment, MD, PhD, Ioannis Konstantinidis, MD, MS, and Eleanor Valenzi, MD, also received numerous honors for their excellence in pulmonary research and commitment to mentoring.
Congratulations to Georgios Kitsios, MD, PhD, on receiving the Jo Rae Wright Award for Outstanding Science as part of the 2024 ATS Respiratory Health Awards. The Jo Rae Wright Award for Outstanding Science recognizes demonstrated potential for significant achievement and contributions. This award is aimed at the rising generation of individuals who will be tomorrow’s leaders in science.Dr. Kitsios was recognized among his peers at the 2024 ATS Annual Meeting for his work in the human microbiome, mechanical ventilation, and infection diagnostics, as well as treating patients with acute respiratory distress syndrome and severe pneumonia.
A team of physician-scientists at the University of Pittsburgh will serve as the editorial board of the research journal JCI Insight for the next five years, under the leadership of Oliver Eickelberg, MD, Dorothy P. and Richard P. Simmons Professor of Pulmonary Research and executive vice chair for academic affairs, Department of Medicine.
UPMC is proud to welcome back Norihisa Shigemura, MD, who began serving as the surgical director of the UPMC Lung Transplant Program and co-chief of Cardiothoracic Transplant in June 2024.
The Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine were well-represented at the American Thoracic Society (ATS) Annual Meeting in San Diego. Our experts spoke and presented research abstracts focusing on a number of important topics relating to pulmonary medicine.
The Division of Pulmonary, Allergy, Critical Care and Sleep Medicine hosted the Pittsburgh International Lung Conference (PILC), which happened on September 19 to 20, 2024. PILC is a comprehensive conference dedicated to exploring the latest advancements and challenges in pulmonary research that brings together leading scientists and health care professionals from around the world to explore key topics shaping the future of lung health.
In this CME, Frank Sciurba, MD, and Melanie Königshoff, MD, PhD, discuss how to identify the variation in disease pattern and progression in COPD, explain current guideline-based therapy limits and the unmet need, and describe the current available and projected future approaches to precision medicine.